JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305895200 on August 13, 2003

J. Biol. Chem., Vol. 278, Issue 45, 44049-44057, November 7, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/45/44049    most recent
M305895200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romero, N.
Right arrow Articles by Denicola, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romero, N.
Right arrow Articles by Denicola, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Reaction of Human Hemoglobin with Peroxynitrite

ISOMERIZATION TO NITRATE AND SECONDARY FORMATION OF PROTEIN RADICALS*

Natalia Romero{ddagger}§, Rafael Radi{ddagger}§||**, Edlaine Linares{ddagger}{ddagger}, Ohara Augusto{ddagger}{ddagger}, Charles D. Detweiler§§, Ronald P. Mason§§, and Ana Denicola§¶¶||||

From the {ddagger}Departamento de Bioquímica and §Center for Free Radical and Biomedical Research, Facultad de Medicina, 11800 Montevideo, Uruguay, {ddagger}{ddagger}Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, CxP 26077, 0513-970 São Paulo, Brazil, §§Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, and ¶¶Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, 11400 Montevideo, Uruguay

Received for publication, June 4, 2003 , and in revised form, July 22, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Peroxynitrite, a strong oxidant formed intravascularly in vivo, can diffuse onto erythrocytes and be largely consumed via a fast reaction (2 x 104 M–1 s–1) with oxyhemoglobin. The reaction mechanism of peroxynitrite with oxyhemoglobin that results in the formation of methemoglobin remains to be elucidated. In this work, we studied the reaction under biologically relevant conditions using millimolar oxyhemoglobin concentrations and a stoichiometric excess of oxyhemoglobin over peroxynitrite. The results support a reaction mechanism that involves the net one-electron oxidation of the ferrous heme, isomerization of peroxynitrite to nitrate, and production of superoxide radical and hydrogen peroxide. Homolytic cleavage of peroxynitrite within the heme iron allows the formation of ferrylhemoglobin in ~10% yields, which can decay to methemoglobin at the expense of reducing equivalents of the globin moiety. Indeed, spin-trapping studies using 2-methyl-2-nitroso propane and 5,5 dimethyl-1-pyrroline-N-oxide (DMPO) demonstrated the formation of tyrosyl- and cysteinyl-derived radicals. DMPO also inhibited covalently linked dimerization products and led to the formation of DMPO-hemoglobin adducts. Hemoglobin nitration was not observed unless an excess of peroxynitrite over oxyhemoglobin was used, in agreement with a marginal formation of nitrogen dioxide. The results obtained support a role of oxyhemoglobin as a relevant intravascular sink of peroxynitrite.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Peroxynitrite,1 a strong oxidant formed intravascularly in vivo by the diffusion-limited reaction between nitric oxide (NO) and superoxide () radicals (15), rapidly oxidizes human oxyhemoglobin (oxyHb)2 (k2 = 2 x 104 M–1 s–1 at 37 °C and pH 7.4 (6,7)) to yield methemoglobin (metHb) as the final product. Peroxynitrite can behave as either a one- or two-electron oxidant during its direct reaction with transition metal centers; therefore, it is not apparent how metHb is formed. Recently, an initial two-electron oxidation process has been proposed leading to the formation of a high oxidation state intermediate, ferrylhemoglobin (ferrylHb) (8, 9). However, the ferrylHb intermediate detected during reaction of oxyHb with peroxynitrite has a very short half-life (i.e. milliseconds), and it can only be clearly observed when trapped with sodium sulfide (8, 9). Even under excess of sodium sulfide, the yields of sulfo-hemoglobin obtained were low (~ 10–15% of metHb yield). This contrasts with the two-electron oxidation product obtained with oxyHb under excess of hydrogen peroxide (H2O2), which yields a relatively stable ferrylHb intermediate (i.e. minutes) that can be observed directly by spectrophotometric techniques (10).

If peroxynitrite oxidizes oxyHb by a two-electron oxidation process, nitrite and molecular oxygen should be produced in addition to ferrylHb (Equation 1):

(Eq. 1)
Neither nitrite nor molecular oxygen yields have been assessed yet, so the mechanism proposed in Equation 1 cannot be confirmed with the available data. Other authors have previously proposed that reaction of oxyHb with peroxynitrite leads to a rapid one-electron oxidation of the heme iron to the ferric form (11). The latter (11) reported the appearance of a ferryl-like spectrum toward the end of the reaction period that was proposed to have been caused by concomitant peroxide production as a result of the presence of nitrite in the peroxynitrite preparations.

Considering that the observed final product of the reaction is metHb (6, 8, 9, 11) and that the ferryl intermediate is transient and detected at low yields, other reaction mechanisms could be considered that involve the formation of intermediate hemoglobin-NOx complexes, such as those observed during the oxidation of oxyHb by NO (12) and probably by NO and/or (13). Indeed, in the oxyHb-mediated oxidation of NO, a transient metHb-peroxynitrite complex is detected that rapidly evolves to metHb and nitrate (12).

(Eq. 2)

A similar complex was also proposed for the isomerization of peroxynitrite catalyzed by metmyoglobin or iron-porphyrins (14, 15).

The alternative scenarios for the peroxynitrite/oxyHb reaction are further complicated by the fact that the reactions of nitrite () and nitrogen dioxide (NO2) with oxyHb could promote the formation of hydrogen peroxide (13, 16) which in turn can secondarily react with oxy- and metHb to yield ferrylHb (Equation 3) or ferrylHb with a second oxidation equivalent centered in the globin moiety, respectively (10, 17, 18).

(Eq. 3)

Regardless of the mechanism considered, a transient ferrylHb is formed during the reaction of peroxynitrite with oxyHb (8, 9) that could be reduced back to metHb by peroxynitrite (Equation 4), nitrite (Equation 5), or globin amino acid residues adjacent to the heme moiety (Equation 6).

(Eq. 4)

(Eq. 5)

(Eq. 6)

The reduction of ferrylHb by peroxynitrite has been proposed (9), but this reaction will only occur under conditions of excess of peroxynitrite with respect to oxyHb. The oxidation of nitrite by ferrylHb can also occur (16), and a kinetic constant for this reaction (7.5 x 102 M–1 s–1 at pH 7.0 and 20 °C) was recently reported (19). Finally, it is possible that the oxo-ferryl complex oxidizes amino acid residues, in which case globin-derived radicals should be detected. This latter possibility is in line with previous results obtained with hydrogen peroxide (10). Thus, the mechanisms by which 1) oxyHb is oxidized, 2) ferrylHb is formed, and 3) ferrylHb is reduced back to metHb still remain to be defined.

The reaction of peroxynitrite with oxyHb is relevant in the context of peroxynitrite reactions and diffusion in the intravascular compartment, because red blood cells and oxyHb may constitute a "sink" for intravascularly formed peroxynitrite (7, 20, 21). Indeed, peroxynitrite can readily cross erythrocyte membranes via anion channel-dependent and simple diffusion mechanisms, and we have previously established that significant amounts of peroxynitrite can reach inside red blood cells, even in the presence of physiological concentrations of carbon dioxide and other fast reacting biotargets of peroxynitrite present in plasma and the extracellular milieu (6, 7, 20).3 Thus, the diffusion of peroxynitrite to red blood cells competes with other routes of peroxynitrite consumption in the intravascular space. Importantly, once in the erythrocyte, the large concentration of hemoglobin (20 mM heme), together with a relatively high rate constant (for a comparison of rate constants of peroxynitrite with biotargets, see Ref. 4), results in a rapid and almost complete intraerythrocytic consumption of peroxynitrite (7). It is important to notice that the reaction of peroxynitrite with intracellular oxyHb (20 mM heme, k = 2 x 104 M–1 s–1) is five to six times faster than that with CO2 (1.3 mM, k = 4.6 x 104 M–1 s–1) at 37 °C, which implies that more than 80% of the peroxynitrite inside red blood cells will react directly with hemoglobin and supports the importance of studying this reaction.

In addition to oxidation reactions, peroxynitrite also promotes the nitration of aromatic compounds such as protein tyrosine residues, a process that requires the intermediate formation of secondary nitrating species. The overall process involves free radical mechanisms in which one-electron oxidants derived from peroxynitrite attack the phenolic ring, leading to formation of a tyrosyl radical, followed by a coupling of the amino acid-derived radical with NO2 to yield 3-nitrotyrosine (22). Yields of nitration by peroxynitrite can be significantly enhanced by ferric iron complexes, which reduce peroxynitrite by one electron, resulting in the formation of NO2 and an oxo-iron complex that could then act as the one-electron oxidant to the phenolic ring. Another iron-dependent nitration mechanism is the one catalyzed by peroxidases, in which ferric heme promotes an initial two-electron reduction of peroxynitrite to yield peroxidase complex I and (23). Complex I can then react quickly with to generate NO2 and compound II (24), both of which can participate in sequential steps that lead to nitration. According to these considerations, the coexistence of significant amounts of ferrylHb and NO2 could promote tyrosine nitration as well (6).

The kinetics of peroxynitrite decomposition and secondary reactions is largely influenced by target concentration (4). Under biologically relevant conditions, oxyHb will be present in large excess over peroxynitrite, a condition that may not always be accomplished when performing mechanistic experiments in vitro. Thus, in this article, we investigate the reaction of peroxynitrite with pure human oxyHb and define the mechanisms that lead to the formation of metHb under experimental conditions that are relevant to the biological chemistry of this reaction in vivo.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals—The following reagents were purchased from Sigma: sulfanilamide, N-(1naphthyl)ethylenediamine dihydrochloride, p-hydroxyphenylacetic acid (PHPA), luminol (5-amino-2,3-dihydro-1,4-phthalazinedione), p-chloromercuribenzoic acid, 2-methyl-2-nitroso propane (MNP), N-ethylmaleimide (NEM), and Pronase. Vanadium (III) chloride was from Aldrich; hydrogen peroxide was from Fluka; 5,5 dimethyl-1-pyrroline-N-oxide (DMPO) was from Alexis; and the anion exchanger DEAE-Sepharose CL-6B was obtained from Pharmacia. Perdeuterated MNP (MNP-d9) was kindly provided by Dr. B. Kalyanaraman (Medical College of Wisconsin, Milwaukee, WI). All other reagents were of research grade quality. Peroxynitrite was synthesized from hydrogen peroxide and nitrous acid as described previously (2527). Contaminating hydrogen peroxide was eliminated with manganese dioxide, and peroxynitrite concentration was determined at 302 nm ({epsilon}302 = 1.67 mM–1 cm–1). The concentration of nitrite in the peroxynitrite preparations was determined by the Griess method (28) using peroxynitrite previously decomposed under acidic conditions (200 mM KH2PO4) that undergoes completely isomerization to nitrate (4). Nitrite contamination was typically less than 30% of the peroxynitrite concentration. The absence of hydrogen peroxide was confirmed by decomposing peroxynitrite in buffer before the assay with horseradish peroxide plus iodide as the second substrate ({epsilon}353 = 25,000 M–1 cm–1; Ref. 29). For all experimental conditions, control runs were performed with peroxynitrite previously decomposed in buffer (reverse order addition experiments). These controls allow discounting the contribution of contaminants of the peroxynitrite preparation and decomposition products in the observed results.

Preparation of Human Oxyhemoglobin—OxyHb was prepared from human erythrocytes (RBC) as described previously (30). Briefly, cells were obtained by centrifugation (800 x g for 10 min) of freshly drawn blood from a healthy donor with heparin as anticoagulant. After the RBC had been washed with 0.15 M NaCl, lysis was achieved by diluting with 3 volumes of distilled water. After 15 min at room temperature, the lysate was centrifuged and the supernatant was diluted in 0.2 volumes of 250 mM Tris-HCl, pH 8.3, and 0.5 mM EDTA. The lysate was then loaded onto a DEAE-Sepharose column (2.5 x 20 cm) previously equilibrated with 50 mM Tris-HCl, pH 8.3, and 0.1 mM EDTA. OxyHb was eluted, applying a pH gradient from 8.3 to 7.0 in the same buffer. The purity of the preparations was assessed by SDS/15% polyacrylamide gel electrophoresis with silver staining, yielding a single protein band around 15.5 kDa, corresponding to the {alpha} and {beta} chains of human hemoglobin. The solution of hemoglobin obtained was more than 95% oxyHb and neither superoxide dismutase (31) nor catalase (32) was detected. FerrylHb was prepared from oxyHb (100 µM in 100 mM phosphate buffer and 0.1 mM DTPA, pH 7.4) by addition of a 5-fold excess of hydrogen peroxide at room temperature. Conversion of oxyHb to ferrylHb was followed spectrophotometrically. After 5 min, catalase was added to eliminate hydrogen peroxide excess and ferrylHb was used immediately.

Concentration of Hemoglobin—The concentration of oxy- and metHb was determined spectrophotometrically by measuring the absorbance at 577 and 630 nm as described by Winterbourn (30): oxyHb (concentration of heme, µM) = 66 A577 80 A630; metHb (concentration of heme, µM) = 279 A630 – 3 A577. In the experiments where ferrylHb was also present in the samples, the concentration of each of the three species (concentration of heme, µM) was determined by measuring the absorbance at 560, 577 and 630 nm and using the following equations derived from the corresponding molar extinction coefficients of each species (30): oxyHb = –1.5 A560 + 68 A577 82 A630; metHb = –79 A560 + 42 A577 + 319 A630; ferrylHb = 96 A560 – 55 A577 – 47 A630. Absorption spectra were collected on a Shimadzu 2100 spectrophotometer.

Modification of Cysteine Residues—{beta}-93 Cys residues were blocked by incubating hemoglobin with 10-fold excess of NEM for 1 h at room temperature and then passed through a Sephadex G-25 column. The amount of total sulfhydryls was quantified before and after treatment by spectrophotometric titration with p-chloromercuribenzoic acid (33). Briefly, aliquots of 5–10 µl of 1 mM p-chloromercuribenzoic acid were added to 1 ml of hemoglobin solutions (20–30 µM) in 50 mM Tris-HCl, pH 7.0, and 1.0% SDS, and the increase in the absorbance at 250 nm was determined. The presence of SDS assured measurement of the total number of thiols present in the molecule. Generally, six thiols/hemoglobin (tetramer) were quantified after hemoglobin purification and four thiols/hemoglobin after treatment with NEM.

Determination of Nitrite and Nitrate—Determination of nitrite was performed by the Griess method (28). To determine total nitrate plus nitrite (), a solution of vanadium (III) chloride (25 mM, final concentration) was added to the Griess reagents to reduce nitrate to nitrite as described previously (34). To avoid secondary reactions during determination, hemoglobin was previously separated by gel filtration. Immediately after each treatment, 100 µl of the samples were passed through a Hi-Trap Desalting column (Amersham Biosciences) and eluted using 50 mM phosphate buffer, pH 7.3, at a flow rate of 5.0 ml/min. After injection of the sample, the fractions that eluted between 20–40 s (hemoglobin) and 50–70 s (total ) were collected for further analysis. Control experiments were performed to assure that under our experimental conditions, the reaction of oxyHb with nitrite present in peroxynitrite preparations does not occur; i.e. all nitrite was recovered and no metHb was observed after sample separation. Dilution of the samples after passage through the column was nearly 20-fold, and it was checked in every experiment with appropriate standard solutions.

Oxymetry Studies—Oxygen evolution studies were performed polarographically using a Cole Parmer oximeter with a Clark type electrode (YSI model 5300). Reactions were performed at 37 °C.

Detection of Hydrogen Peroxide as a Reaction Product—Hydrogen peroxide was detected by chemiluminescence with luminol using an assay based on the pseudo-peroxidase activity of hemoglobin (35). This method was the most appropriate because of its sensitivity and because it overcomes the loss of H2O2 from reactions with oxy- and metHb that occurs during the sample processing that other techniques would require. Briefly, peroxynitrite (250 and 500 µM) was added to oxyHb (1.0 mM) in 100 mM phosphate buffer, and 0.1 mM DTPA, pH 7.3; immediately after, 100 µl of the sample was placed in a tube containing 3.0 ml of luminol (10 µM) in 200 mM phosphate buffer, pH 7.8, and 0.3 mM DTPA. Chemiluminescence was monitored using a Thorn-Emi photon counter equipped with an EMI Fact 50 MK III Photomultiplier cooled to –20 °C (36). The voltage in the photomultiplier was kept at 1350 V. The reactions were always carried out in glass tubes that were kept at 25 °C by a temperature-controlled water bath.

EPR Experiments—The EPR spectra were recorded at room temperature (25 °C) on a Bruker EMX EPR spectrometer. The reaction mixtures (200 µl, final volume) were transferred to 100-µl flat cells immediately after peroxynitrite addition and the spectra recorded within 1 min. The magnetic field was calibrated with 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy radical (g = 2.0056). MNP stock solution (1.0 M, monomer) was prepared in acetonitrile (high pressure liquid chromatography quality). The MNP-Hb radical concentration was estimated by using a 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy radical standard (145 µM) in 50% glycerin. The calibration experiments were performed by using a fingertip Dewar flask containing liquid nitrogen.

SDS-PAGE and Western Blot Analysis—All experiments were carried out at 25 °C unless otherwise indicated. To rule out any contribution of nitrite present in peroxynitrite preparations, samples were passed through Sephadex-G25 immediately after treatment and then stored at 4 °C until preparation for electrophoresis. Reaction mixtures containing human hemoglobin samples were separated on 15% polyacrylamide gels using SDS-PAGE. The gels were either silver-stained for protein band visualization or electrophoretically transferred (100 V, 1 h) to nitrocellulose membranes (Hybond-C extra; Amersham Biosciences) for Western blot analysis.

Protein bands transferred to nitrocellulose membranes were stained and fixed using non-permanent 2% Ponceau S in 30% trichloroacetic acid for 20 min, scanned, and then destained overnight with deionized water. Immunodetection of DMPO nitrone adducts on the hemoglobin was measured using a recently developed anti-DMPO nitrone antiserum, which binds to the one-electron oxidation product of the initial DMPO nitroxyl spin adducts (37). For DMPO nitrone adduct analysis, destained nitrocellulose membranes were blocked for 90 min in blocking solution (2.5% bovine serum albumin, 2.5% non-fat milk in 50 mM Tris buffered saline). The membranes were washed for 2 min in wash buffer (0.05% bovine serum albumin, 0.05% non-fat milk, 0.05% Tween 20 in 50 mM Tris-buffered saline), then incubated for 90 min with the primary rabbit antiserum anti-DMPO nitrone diluted 1:5000 in wash buffer (37). After extensive washing in the same buffer, the membranes were incubated 60 min with the secondary antibody, anti-rabbit IgG conjugated to alkaline phosphatase (Pierce Chemical Co., Rockford, IL), diluted 1:5000 in wash buffer. After a second series of wash steps, to remove the unbound secondary antibody, immunoreactive proteins were detected using the Immun-Star Chemiluminescent Kit (Bio-Rad) following the commercial protocol.

The immunochemical detection of protein nitrotyrosine was carried out with a highly specific polyclonal anti-nitrotyrosine antibody developed in our laboratory as described in Ref. 38. The membranes were blocked for 60 min in 5% bovine serum albumin and 0.6% Tween 20 in 50 mM Tris-buffered saline, followed by incubation for 60 min with the primary antibody diluted 1:1000 in the blocking solution and, after that, extensive washing with 0.6% Tween 20 in 50 mM Tris-buffered saline solution. The steps of the procedure remaining were performed as described for the anti-DMPO nitrone antibody.

The use of a secondary antibody conjugated with alkaline phosphatase, instead of peroxidase, was necessary to avoid false positive data caused by the pseudo-peroxidase activity of hemoglobin.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Determination of Nitrite and Nitrate—The analysis of nitrogen-containing products after reaction of oxyHb with a substoichiometric amount of peroxynitrite was performed to elucidate the reaction mechanism. Table I shows the amount of metHb, nitrite, and nitrate obtained after reaction of oxyHb with peroxynitrite. The data shows a nearly stoichiometric formation of metHb, with yields of 80 to 100% with respect to added peroxynitrite and a similar or higher nitrate yield. On the other hand, and surprisingly, we observed a net consumption of nitrite present in peroxynitrite preparations that had evolved to nitrate, because nitrate values were typically higher than the amount of peroxynitrite added. Overall, the result suggests that nitrite is not being produced, contrary to the mechanism of Equation 1. It could be argued that peroxynitrite was first reduced to nitrite with concomitant formation of ferrylHb (Equation 1); afterward, the totality of produced nitrite was consumed by the ferryl species. However, if nitrite were being oxidized to NO2 by ferrylHb (Equation 5), the final observed products would be 0.5 + 0.5 per mol of nitrite reduced, as was previously reported (19). Indeed, reaction of hydrogen peroxide with oxyHb (which gives ferrylHb) in the presence of nitrite showed the predictable stoichiometric consumption of 0.5 nitrite per metHb formed (Table I). So, the reactions proposed in Equations 1 and 5 could not explain the absence of nitrite detection observed in the experiment and a higher than stoichiometric formation of nitrate.


View this table:
[in this window]
[in a new window]
 
TABLE I
Nitrite and nitrate formed from the reaction of oxyHb (1.0 mM) with a substoichiometric amount of peroxynitrite

Concentrations of nitrite () are expressed as the difference between the value determined in the hemoglobin samples minus the value of nitrite present in peroxynitrite preparations. The nitrate values represent the amount formed from the hemoglobin reaction.

 

Fig. 1 shows the decay of ferrylHb (25 µM) preformed with an excess of H2O2. FerrylHb alone was rather stable, and the decay was moderately enhanced in the presence of or PHPA, indicating that both compounds were able to reduce ferryl- to metHb. Thus, the presence of nitrite during peroxynitrite exposures does not explain the short half-life and yield of ferrylHb previously reported (9). To further discount the possibility that nitrite was produced as in Equation 1 and then consumed by ferrylHb, the oxyHb-peroxynitrite reaction was performed in the presence of PHPA, at a concentration that would kinetically compete with nitrite for reaction with ferrylHb. Nevertheless, yields of nitrite and nitrate obtained in the presence and absence of PHPA were identical (Table I), supporting the idea that nitrite is not being significantly consumed by ferrylHb during the reaction mechanism.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1.
Time course of ferrylHb reduction to metHb. Decay of ferrylHb (25 µM) in 100 mM phosphate buffer and 0.1 mM DTPA, pH 7.4 ({blacksquare}) and after addition of 100 µM sodium nitrite ({circ}) or 25 mM PHPA (•). Spectra were collected every 30 s and ferrylHb concentration was determined as described under "Materials and Methods."

 

Consumption of nitrite by oxyHb, either added directly or from pre-decomposed peroxynitrite, was not detected at times <60 s, in agreement with a rather slow reaction (16).

Yields of Oxygen Evolution—When oxyHb (500 µM) was oxidized by peroxynitrite (100–400 µM), oxygen evolution was detected (Fig. 2A). Oxygen was mostly released within a fast phase, consistent with the reaction time of peroxynitrite (i.e. within the response time of the oxygen sensor) followed by a slow phase (up to 2 min), which possibly reflects comproportionation reactions between ferrylHb and oxyHb (10). Oxygen yields were only near 30% with respect to metHb formed (Fig. 2B). No oxygen evolution was detected after addition of predecomposed peroxynitrite or an equivalent amount of nitrite at times <60 s. On the other hand, treatment of oxyHb (500 µM) with hydrogen peroxide, known to perform a two-electron oxidation (Equation 3; Ref. 10), resulted in oxygen yields twice as high (~70%). Finally, oxidation by the one-electron oxidant ferricyanide anion (K3Fe(CN)6) yielded 100% of metHb and oxygen, and no slow phase was observed (Fig. 2B).



View larger version (25K):
[in this window]
[in a new window]
 
FIG. 2.
Oxygen evolution yields during oxyhemoglobin oxidation. A, OxyHb (500 µM) in 100 mM phosphate buffer and 0.1 mM DTPA, pH 7.4, was oxidized with peroxynitrite (120, 350 µM), and oxygen evolution was registered using a Clark-type oxygen electrode. MetHb yields measured after 2 min of reaction were 141 and 346 µM, respectively. B, oxygen evolution yields during oxyHb (500 µM) oxidation by increasing concentrations of K3Fe(CN)6 (73, 146, 219 µM)({blacktriangleup}), H2O2 (350 µM) ({blacktriangledown}), peroxynitrite (114, 230, 380 µM) (•), or when oxyHb was previously treated with NEM and then with peroxynitrite ({blacksquare}). NEM-treated oxyHb consistently increased oxygen yields by ~5% with respect to oxyHb in the presence of peroxynitrite, as determined in three experiments performed on different days.

 

It is well known that amino acid-derived radicals such as thiyl and tryptophanyl consume oxygen (39, 40). However, oxygen evolution was consistently but only marginally enhanced when oxyHb was pretreated with NEM, indicating that cysteine residues, despite being involved in the process, were not responsible for significant oxygen consumption. It is important to note that under the oxyHb/peroxynitrite concentration ratio used in the experiments, most peroxynitrite reacts directly with oxyHb and the homolysis to hydroxyl (OH) and nitrogen dioxide (NO2) radicals is not significant (k = 0.26 s–1 at 25 °C and pH 7.4; Ref. 41); therefore, any one-electron oxidation of amino acids would depend on secondary intermediates after peroxynitrite reaction with the heme (e.g. ferrylHb). Although tryptophan-derived radicals (see below) could also contribute to oxygen consumption and partially explain differences between oxygen yields obtained with two-versus oneelectron oxidants (because the latter do not produce ferrylHb), this cannot explain the difference in yields observed between peroxynitrite (~30%) and hydrogen peroxide (~70%) if both mechanisms proceed via two-electron oxidation.

Detection of Hydrogen Peroxide—Because the reaction of peroxynitrite with oxyHb mainly yielded nitrate (an isomerization product) and oxygen yields were significantly less than predicted from a two-electron oxidation, we explored alternative mechanisms to account for the redox reaction leading to metHb. In this context, we evaluated the potential reduction of oxygen bound to the ferrous heme. For this, we studied the formation of hydrogen peroxide by chemiluminescence techniques. Hydrogen peroxide could arise secondary to the dismutation of superoxide radical anion formed from a one-electron transfer from the ferrous heme to bound oxygen or directly if a two-electron transfer to oxygen occurred. The reaction of H2O2 with oxy- or metHb results in a ferryl species similar to peroxidase compound II or compound I, respectively, that reacts with the chemiluminescence probe luminol, promoting light emission (35). Fig. 3 shows chemiluminescence obtained when peroxynitrite (250, 500 µM) was added to oxyHb (1.0 mM) and the reaction mixture was immediately placed in a tube containing luminol. Light emission was indicative of ferrylHb formation. The signal obtained was ~50% inhibited when catalase was added 5 s after peroxynitrite. The intensity of the catalaseinhibitable signal was similar to that obtained by addition of 250 µM H2O2 to the oxyHb solution. No signal was obtained by pre-decomposed peroxynitrite, disproving the formation of hydrogen peroxide from the direct reaction of oxyHb with contaminant nitrite present in peroxynitrite preparations. The data supports the idea that ferrylHb is formed as a consequence of both the reaction with peroxynitrite and secondary to hydrogen peroxide formation, which is produced in about 50% yield with respect to peroxynitrite.



View larger version (42K):
[in this window]
[in a new window]
 
FIG. 3.
Detection of hydrogen peroxide formation. OxyHb (1.0 mM) in 100 mM phosphate buffer and 0.1 mM DTPA, pH 7.4, was treated with peroxynitrite and immediately after assayed for luminol chemiluminescence. Treatments were 250 and 500 µM peroxynitrite; 500 µM peroxynitrite + catalase (50,000 units/ml) added 5 s after; and 250 µM H2O2 and reverse order addition of peroxynitrite (R.O.A.). The inset shows a typical time course of chemiluminescence (e.g. 500 µM peroxynitrite).

 

Spin Trapping of Globin Radicals—Fig. 4 shows EPR spectra of MNP radical adducts obtained during incubation of oxyHb with peroxynitrite followed by addition of MNP 15 s after peroxynitrite. This order of addition was intended to minimize direct interactions of peroxynitrite and secondary reactive species with the spin trap. The immobilized signal obtained (Fig. 4A) is characteristic of an adduct between MNP and an amino acid-derived radical. The presence of CO2 added in the same concentration ratio as observed in RBC (oxyHb: CO2 = 15) did not affect the immobilized signal obtained (data not shown). Calibration experiments using 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy radical as standard indicated a ~6% yield of trapped protein radicals with respect to added peroxynitrite. These results suggest that formation of protein radicals represent a secondary pathway during oxyHb oxidation. The spin adduct was subjected to nonspecific proteolysis with Pronase (final concentration, 20 mg/ml), resulting in the conversion of the spectrum into an isotropic three-line spectrum with a hyperfine coupling constant of 15.4 G (Fig. 4B). An identical signal has previously been reported for the adduct formed between MNP/cytochrome c (42) or MNP/metMb (43) treated with H2O2 and was assigned to a radical located on a tertiary carbon atom. The experiment was then repeated using MNP-d9 to increase the resolution of the superhyperfine structure. A similar three-line spectrum was detected when MNP-d9 was used as the spin trap (data not shown). When the low-field line of this triplet was scanned using a smaller modulation amplitude, the superhyperfine structure shown in Fig. 4C was obtained. Comparison of this signal with that obtained with authentic MNP-d9/Tyr generated by oxidation of the free amino acid by horseradish peroxidase (44, 45) strongly supports the idea that tyrosyl radical is formed during oxyHb reaction with peroxynitrite. Addition of H2O2 or H2O2 plus pre-decomposed peroxynitrite yields an EPR signal after 60 s that is significantly lower (<10%) than the one obtained with peroxynitrite (data not shown). These results are in agreement with an early formation of amino acid-derived radicals, mainly because of peroxynitrite-dependent ferrylHb formation and not secondary reactions caused by H2O2 production.



View larger version (13K):
[in this window]
[in a new window]
 
FIG. 4.
EPR spectra obtained from the reaction of oxyHb with peroxynitrite in the presence of MNP or MNP-d9. A, OxyHb (1 mM) treated with peroxynitrite (1 mM) in the presence of MNP (20 mM). Sample was collected 1.5 min after peroxynitrite addition. B, 120 µl of the sample of spectrum (A) was treated with Pronase (2.5 mg) and the spectrum was collected 6 min after peroxynitrite addition. C, higher resolution spectrum of the low field line of spectrum B using MNP-d9. Instrument settings were as follows: modulation amplitude, 5.0 G (A), 1.0 G (B), and 0.14 G (C); time constant, 81.9 ms (A and B) and 1310 ms (C); scan time, 1.19 G/s (A), 0.42 G/s (B), 0.036 G/s (C); receiver gain, 1 x 105; microwave power, 20 mW.

 

To obtain further information concerning the identity of the protein radicals generated by the reaction of oxyHb with peroxynitrite, experiments were also performed with the spin trap DMPO. When oxyHb was treated with peroxynitrite in the presence of 100 mM DMPO, a four-line spectrum was obtained, with a {beta}-hydrogen splitting constant value of 15.4 G, which is consistent with those previously assigned to other DMPO/protein-thiyl radical adducts (Fig. 5) (46, 47). No immobilized signal was observed with DMPO when reactive Cys-93 were blocked with NEM; the weak signal observed is compatible with the formation of an oxidation product of DMPO, 5,5-dimethyl-2-ketopyrrolidone-N-oxyl (aN = 7.2 G and aH{beta} (2H) = 3.9 G), reported previously (45, 48, 49). Overall, these results are consistent with one-electron oxidation of globin amino acids by ferrylHb.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 5.
EPR spectra of DMPO adducts obtained during the reaction of oxyHb with peroxynitrite. OxyHb (4 mM) (A) or thiolblocked oxyHb (NEM-oxyHb) (B) treated with peroxynitrite (1 mM) in the presence of DMPO (50 mM) in 100 mM phosphate buffer, pH 7.4, and 0.1 mM DTPA. The spectra were collected 1.5 min after peroxynitrite addition. Instrumental conditions: modulation amplitude, 2.0 G; time constant, 81.9 ms; scan time, 0.60 G/s; receiver gain, 4 x 104; microwave power, 20 mW.

 

Detection of Dimerization Products by SDS-PAGE—To further investigate secondary oxidative modifications in the globin moiety, we evaluated the formation of cross-links between hemoglobin subunits. Indeed, dimers of hemoglobin chains were obtained after peroxynitrite treatment in a dose-dependent manner (Fig. 6). Importantly, 1) the dimers were obtained with less than a stoichiometric amount of peroxynitrite and 2) no dimer formation was observed during oxyHb oxidation by ferricyanide (data not shown). Thus, the data is consistent with ferrylHb-dependent formation of globin-derived radicals followed by radical recombination/dimerization. In this regard, two types of cross-linked species were detected (i.e. mercaptoethanol reducible (Fig. 6, lanes 6–9) and non-reducible (Fig. 6, lanes 2–5)), in agreement with the formation of intermolecular disulfide bridges and dityrosine, respectively. Covalent linkage between {beta}-93 cysteines and {alpha}-tyrosines 42 and 24 has been reported after reactions of peroxynitrite and oxyHb in the presence of CO2 (21). No differences were observed when 100 µM ascorbate was added as a reductant to the electrophoresis loading buffer, ruling out cross-linking caused by oxidation during the denaturalization process (data not shown) (21).



View larger version (36K):
[in this window]
[in a new window]
 
FIG. 6.
Evidence of cross-linked dimers as final products of the reaction. OxyHb (500 µM) was treated with 115 µM (lanes 2 and 6), 230 µM (lanes 3 and 7), or 380 µM (lanes 4 and 8) peroxynitrite in 100 mM phosphate buffer, pH 7.4, and 0.1 mM DTPA and analyzed by SDS-PAGE under reducing (lanes 2–5) and non-reducing (lanes 6–9) conditions. Lanes 5 and 9 correspond to reverse-order addition of lanes 4 and 8, respectively. Lane 1, molecular mass markers.

 

Immunochemical Detection of DMPO-Hemoglobin Adducts— To further support the role of amino acid-derived radical recombination reactions in the formation of dimers of hemoglobin chains, it was observed that peroxynitrite oxidation of oxyHb in the presence of DMPO leads to an inhibition of dimer formation (Fig. 7A). The inhibitory effect of DMPO (5–225 mM) was concentration-dependent. Because there is no significant direct reaction of peroxynitrite with DMPO (50) and because DMPO-globin radical adducts were detected by EPR (Fig. 5), the decrease in dimer formation can be attributed to the trapping of tyrosyl and thiyl radicals. The formation of DMPO-hemoglobin adducts was evaluated immunochemically by the use of an anti-DMPO nitrone antibody, which has just been developed (37). This antibody recognizes the one-electron oxidation product of the initial nitroxyl spin adduct, the nitrone of DMPO, which is an EPR-silent but stable product (37). Using this antibody with the oxyHb samples treated with peroxynitrite in the presence of DMPO, we found the formation of DMPO-globin monomer adducts (Fig. 7C). Interestingly, when oxyHb was pretreated with NEM, peroxynitrite addition in the presence of DMPO led to a larger amount of adduct detected and complete inhibition of dimer formation (Fig. 7, B and C). This indicates that although under our experimental conditions only DMPO-thiyl globin radicals were detected by EPR, DMPO can also add to amino acid-derived radicals different from cysteinyl and is consistent with the antibody avidly recognizing DMPO nitronetyrosyl hemoglobin adducts (51).



View larger version (44K):
[in this window]
[in a new window]
 
FIG. 7.
Detection of DMPO-adducts and dimerization products. A, OxyHb (500 µM) was treated with peroxynitrite (350 µM) in the presence of increasing concentrations of DMPO (0, 5, 25, 75, and 225 mM). Samples were analyzed by SDS-PAGE under reducing (lanes 1–5) and non-reducing conditions (lanes 6–10). All lanes contained 10 µg of hemoglobin. B and C, OxyHb (0.5–4 mM) or NEM-oxyHb (0.5–4 mM) was treated with peroxynitrite (0.25–2 mM) in the presence of 100 mM DMPO in 100 mM phosphate buffer, pH 7.4, and 0.1 mM DTPA. In all conditions, the oxyHb/peroxynitrite ratio was 2:1. The samples were analyzed by SDS-PAGE under reducing conditions (B) and then transferred to nitrocellulose and immunostained with anti-DMPO nitrone antibody (C). Lane 1 contained molecular mass markers; other lanes contained 5 µg of hemoglobin as follows: lane 2, oxyHb; lanes 3, 5, and 7, oxyHb (0.5, 2.0 and 4.0 mM) treated with peroxynitrite (0.25, 1.0 and 2.0 mM, respectively); and lanes 4, 6, and 8, oxyHb-NEM (0.5, 2.0, and 4.0 mM, respectively) treated with peroxynitrite (0.25, 1.0, and 2.0 mM, respectively).

 

Immunochemical Detection of Nitrotyrosine—Under excess of oxyHb over peroxynitrite, no 3-nitrotyrosine in hemoglobin was detected, as assessed immunochemically (Fig. 8) even under longer film exposure time. However, at low hemoglobin concentrations (where peroxynitrite homolysis to OH and NO2 becomes relevant) or as the peroxynitrite/hemoglobin ratio increases, nitration can be observed. Nitration requires the formation of tyrosyl radicals and NO2, which necessarily involve the participation of ferrylHb for oxidation of tyrosine residues and/or nitrite or homolysis of peroxynitrous acid (4, 22). The fact that no 3-nitrotyrosine was detected with an excess of oxyHb over peroxynitrite supports the concept that the yields of ferrylHb and/or NO2 are modest. Together, the data indicate that under biologically relevant conditions, no significant peroxynitrite-dependent nitration of hemoglobin will be expected.



View larger version (43K):
[in this window]
[in a new window]
 
FIG. 8.
Detection of nitrotyrosine in oxyHb treated with high concentrations of peroxynitrite. Western blot for nitrotyrosine of oxyHb (1–4 mM) treated with peroxynitrite (as indicated) in 100 mM phosphate buffer, pH 7.4, and 0.1 mM DTPA. Samples were analyzed by SDS-PAGE under non-reducing conditions before transferring to nitrocellulose membrane. All lanes contain 10 µg of protein.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The studies presented herein show that oxyHb oxidation by peroxynitrite results in the stoichiometric formation of nitrate and metHb (Table I), and a fractional formation (~50%) of oxygen (Fig. 2) and hydrogen peroxide (Fig. 3). A small percentage (~6%) of protein radicals were trapped (Figs. 4, 5, and 7) although no nitrite was formed; in fact, pre-existing nitrite in peroxynitrite preparations was partially consumed (Table I). These observations are consistent with a reaction mechanism that implies the isomerization of peroxynitrite to nitrate and oxyHb oxidation at the expense of the reduction of the molecular oxygen bound to the ferrous heme:

(Eq. 7)

(Eq. 8)

(Eq. 9)

(Eq. 10)

(Eq. 11)

(Eq. 12)

In this mechanism, peroxynitrite reacts with oxyHb (best described as an intermediate form between iron(II)-dioxygen and an iron(III)-superoxide complex Equation 7; Refs. 52, 53) to yield superoxide radical anion and a metHb-peroxynitrite intermediate (Equation 8), followed by a rapid ferric heme-catalyzed peroxynitrite decomposition via O–O bond homolysis to "caged" ferrylHb and NO2 (Equation 9). Recombination of the NO2 radical with ferrylHb within the heme cavity would mainly yield metHb and (Equation 10), whereas a small fraction of the radicals could diffuse out (Equation 11) and yield NO2 and ferrylHb. Ferric iron could act as a Lewis acid and catalyze the isomerization of peroxynitrite to nitrate (4, 54) as has been already reported for iron(III) porphyrins and metmyoglobin (14, 15). A similar transient metHb-peroxynitrite complex was detected during the NO-mediated oxidation of oxyHb, which rapidly evolves to metHb and nitrate (12). Importantly, oxidation of oxymyoglobin by NO also yields an intermediate complex, which promotes the oxidation of ethylene-1,2-13C as detected by NMR (13); this result indicates that a hydroxyl radical-like species arises at low yields from the iron-catalyzed homolysis of complexed peroxynitrite and that it can escape the solvent cage to initiate free radical chemistry (13). In addition, superoxide anion released in the first step of the reaction (Equation 8) would spontaneously dismutate to O2 and H2O2 (Equation 12), which would initiate secondary oxidation reactions in oxy- or metHb to ferrylHb (10, 17, 18) and promote consumption of pre-existing nitrite in peroxynitrite preparations (Table I), which is facilitated by autocatalytic mechanisms (16)

The oxidation of oxyHb by peroxynitrite yields a transient ferrylHb intermediate (8, 9). This observation contrasts with the stability of the ferrylHb intermediate formed under excess of H2O2 (10, 55), which can be observed even in the presence of nitrite (Fig. 1). However, although the reported H2O2-derived ferrylHb probably arises from the two-electron oxidation of metHb and therefore contains a second oxidation equivalent in the globin moiety, the ferrylHb formed from the reaction of limiting oxidant (e.g. peroxynitrite) with oxyHb involves only a two-electron oxidation of the heme. Peroxynitrite-derived ferrylHb can be observed only if trapped with excess sulfide at relatively low yields (~15%), and it ultimately undergoes a one-electron reductive step to metHb. Under biologically relevant conditions, the reduction of ferrylHb by peroxynitrite is unlikely because the rate constants of peroxynitrite with oxyHb and ferrylHb (9) are similar (8.8 x 104 and 9.4 x 104 M–1 s–1 at pH 7 and 20 °C), and the concentration of ferryl- compared with oxyHb is negligible under any circumstance. Reduction of ferrylHb by nitrite (16) is not expected to represent a relevant pathway because of kinetic limitations (Fig. 1) (19). The decay of the ferryl intermediate that can occur by reaction with nearby amino acids such as tyrosine, cysteine, or tryptophan would result in the formation of globin-derived radicals that favor some oxygen consumption and intermolecular cross-links (56). In this regard, cysteinyl and tyrosyl radicals were spin-trapped as detected by EPR and/or immunochemically (Figs. 4, 5, and 7) and intermolecular cross-linked products were formed (Fig. 6). Formation of amino acid-derived radicals by direct reactions of cysteine or tyrosine with peroxynitrite are ruled out because: 1) the second-order rate constant of {beta}-Cys-93 with peroxynitrite has been determined as 1.5 x 10–3 M–1 s–1 per thiol group,4 a value nearly 25 times smaller than reaction of oxyhemoglobin with peroxynitrite, considering that there are two reactive cysteines per hemoglobin tetramer; 2) direct reaction of peroxynitrite with thiols result in two-electron oxidation products (e.g. cysteine sulfenic acid), not the cysteinyl radical (27, 57); and 3) there is no direct reaction between peroxynitrite and tyrosine (58). Note that another two-electron oxidant of oxyHb, such as hydrogen peroxide, also leads to substoichiometric oxygen detection, whereas a one-electron oxidant, such as ferricyanide, which does not yield ferrylHb, results in 100% oxygen release (Fig. 2B).

In RBC, another mechanism of ferrylHb consumption should be considered, such as its one-electron reduction by glutathione (5 mM inside RBC), which yields metHb and glutathionyl radical without initial formation of globin-derived radicals (59). Alternatively, glutathionyl radicals may be produced by the reaction of glutathione with globin-derived radicals that would then be repaired (59).

Two important kinetic considerations must be taken into account when interpreting the data presented herein. First, under our experimental conditions of oxyHb >=1 mM and equal or lower concentrations of peroxynitrite, most peroxynitrite will react directly with oxyHb and minimal amounts will undergo homolysis to OH and NO2 (k = 0.26 s–1 at 25 °C and pH 7.4) (41). Thus, the radical pathway depends on the presence of ferrylHb and not on secondary radicals arising from peroxynitrite decomposition. Second, DMPO, which was added as a spin trap for both EPR and immunochemical studies, does not react directly with peroxynitrite (50); therefore, the DMPO concentrations used (up to 100 mM) do not influence the initial reaction of oxyHb with peroxynitrite. Thus, the effects of DMPO are related to the trapping of secondary globin-derived radicals (Figs. 5 and 7) and perhaps some minor reaction with the ferryl intermediate (Fig. 5) (45, 48). We cannot define which of the ferrylHb-oxidized amino acids detected using the spin traps MNP and DMPO (i.e. tyrosyl and cysteinyl radicals) are the initial radicals or whether they are formed after intramolecular electron transfer (60). Recent observations using peroxynitrite-treated RBC lysates have also suggested the occurrence of both inter- and intramolecular electron transfer processes leading to the detection of different amino acid-derived radicals depending on the spin trap or hemoglobin concentration used (59).

In contrast to what is observed during peroxynitrite-dependent, one-electron oxidation of hemeperoxidases and other transition metal-containing centers, which yield NO2 and favor nitration reactions (23, 61), the mechanism of oxidation of oxyHb by peroxynitrite revealed herein circumvents nitration reactions because NO2 and nitrite are scarcely or not formed, respectively. Despite this, oxyHb nitration can be observed if excess peroxynitrite over oxyHb is present or under conditions of low oxyHb concentrations in which peroxynitrite can yield OH and NO2.

In summary, oxyHb reacts fast and isomerizes peroxynitrite to nitrate with the concomitant net one-electron oxidation of the ferrous heme to the ferric state and production of . There is an accompanying substoichiometric formation of transient ferrylHb and protein-derived radicals and a negligible incidence of nitrating species. Inside RBC, the H2O2 produced after peroxynitrite reactions will not significantly react with oxyHb because this reaction is quite slow (k2 = 100 M–1 s–1 (10)) but would be mainly removed by the action of glutathione peroxidase and catalase. Thus, the present results are compatible with a mechanism of oxyHb oxidation by peroxynitrite under biologically relevant conditions as indicated in Fig. 9 and point to oxyHb as a relevant intravascular sink of peroxynitrite.



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 9.
Proposed mechanisms for the reaction of oxyhemoglobin with peroxynitrite. Peroxynitrite reacts with oxyHb, displacing superoxide radical anion to yield a metHb-peroxynitrite intermediate (I). Ferric-heme catalyzes peroxynitrite decomposition via O–O bond homolysis to yield "caged" ferrylHb and NO2 (II), which mainly recombine within the heme cavity, yielding metHb and (III), or diffuse outside heme to yield NO2 and ferrylHb (IV). FerrylHb could be reduced back to metHb by a proximal amino acid residue, yielding globin-centered radicals such as tyrosyl and cysteinyl radicals (V); the amino acid-derived radical could then oxidize a second oxyHb molecule (comproportionation reaction) (VI), add an O2 molecule to yield an oxidized amino acid (VII), or react with another amino acid-derived radical to form interchain dimers (VIII). In addition, superoxide radical anion previously released spontaneously dismutates, yielding O2 and H2O2 (IX), which promote secondary oxidation reactions.

 


    FOOTNOTES
 
* This work was supported by grants from Consejo Nacional de Investigación Científica y Tecnológica (to N. R.), Comisión Sectorial de Investigación Científica and Third World Academy of Science (to A. D.), The Howard Hughes Medical Institute (to R. R.), and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (to O. A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

Partially supported by a fellowship from Programa de Desarrollo de las Ciencias Básicas (PEDECIBA, Uruguay). Back

|| Fellow of the John Simon Guggenheim Memorial Foundation and a Howard Hughes International Research Scholar. Back

** To whom correspondence may be addressed: Departamento de Bioquímica, Facultad de Medicina, Avda. Gral. Flores 2125, 11800 Montevideo, Uruguay; Tel.: 5982-924-95-61; Fax: 5982-924-95-63; E-mail: rradi{at}fmed.edu.uy.

|||| To whom correspondence may be addressed: Laboratorio de Fisicoquímica Biológica, Instituto de Química Biológica, Facultad de Ciencias, Iguá 4225, 11400 Montevideo, Uruguay; Tel.: 5982-525-86-18 (ext. 214); Fax: 5982-525-07-49; E-mail: denicola{at}fcien.edu.uy.

1 IUPAC recommended names for peroxynitrite anion (ONOO) and peroxynitrous acid (ONOOH) are oxoperoxonitrate (1–) and hydrogen oxoperoxonitrate, respectively. The term peroxynitrite is used to refer to the sum of ONOO and ONOOH. Back

2 The abbreviations used are: oxyHb, oxyhemoglobin; metHb, methemoglobin; ferrylHb, ferrylhemoglobin; PHPA, p-hydroxyphenylacetic acid; MNP, 2-methyl-2-nitroso propane; NEM, N-ethylmaleimide; DMPO, 5,5-dimethyl-1-pyrroline N-oxide; DTPA, diethylenetriaminepentaacetic acid; EPR, electron paramagnetic resonance; RBC, red blood cells; MNP-d9, perdeuterated 2-methyl-2-nitroso propane. Back

3 In diffusion experiments using fresh blood (45% hematocrit in heparinized plasma), 20% of extracellularly added peroxynitrite could reach the inside of red blood cells and oxidize oxyHb (N. Romero, A. Denicola, and R. Radi, unpublished results). Back

4 N. Romero, R. Radi, and A. Denicola, unpublished observations. Back


    ACKNOWLEDGMENTS
 
We thank Mary J. Mason for her language assistance in the preparation of the manuscript, Dr. Carlos Batthyány (Facultad de Medicina, Universidad de la República) for providing expertise on nitrite/nitrate measurements, and Dr. Jin-Jie Jiang (NIH/NIEHS) for assistance in the calibration of the protein-MNP radical adduct signal.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Moncada, S., Palmer, R. M., and Gryglewski, R. J. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 9164–9168[Abstract/Free Full Text]
  2. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 9265–9269[Abstract/Free Full Text]
  3. Palmer, R. M., Ferrige, A. G., and Moncada, S. (1987) Nature 327, 524–526[CrossRef][Medline] [Order article via Infotrieve]
  4. Radi, R., Denicola, A., Alvarez, B., Ferrer-Sueta, G., and Rubbo, H. (2000) in Nitric Oxide: Biology and Pathobiology (Ignarro, L. J., ed) pp. 57–82, Academic Press, New York.
  5. Wolin, M. S. (2000) Arterioscler. Thromb. Vasc. Biol. 20, 1430–1442[Abstract/Free Full Text]
  6. Denicola, A., Souza, J. M., and Radi, R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 3566–3571[Abstract/Free Full Text]
  7. Romero, N., Denicola, A., Souza, J. M., and Radi, R. (1999) Arch. Biochem. Biophys. 368, 23–30[CrossRef][Medline] [Order article via Infotrieve]
  8. Minetti, M., Scorza, G., and Pietraforte, D. (1999) Biochemistry 38, 2078–2087[CrossRef][Medline] [Order article via Infotrieve]
  9. Exner, M., and Herold, S. (2000) Chem. Res. Toxicol. 13, 287–293[Medline] [Order article via Infotrieve]
  10. Giulivi, C., and Davies, K. J. (1990) J. Biol. Chem. 265, 19453–19460[Abstract/Free Full Text]
  11. Alayash, A. I., Ryan, B. A., and Cashon, R. E. (1998) Arch. Biochem. Biophys. 349, 65–73[Medline] [Order article via Infotrieve]
  12. Herold, S. (1999) FEBS Lett. 443, 81–84[CrossRef][Medline] [Order article via Infotrieve]
  13. Wade, R. S., and Castro, C. E. (1996) Chem. Res. Toxicol. 9, 1382–1390[CrossRef][Medline] [Order article via Infotrieve]
  14. Bourassa, J. L., Ives, E. P., Marqueling, A. L., Shimanovich, R., and Groves, J. T. (2001) J. Am. Chem. Soc. 123, 5142–5143[Medline] [Order article via Infotrieve]
  15. Jensen, M. P., and Riley, D. P. (2002) Inorg. Chem. 41, 4788–4797[CrossRef][Medline] [Order article via Infotrieve]
  16. Kosaka, H., Imaizumi, K., and Tyuma, I. (1981) Biochim. Biophys. Acta 702, 237–241
  17. McArthur, K. M., and Davies, M. J. (1993) Biochim. Biophys. Acta 1202, 173–181[CrossRef][Medline] [Order article via Infotrieve]
  18. Patel, R. P., Svistunenko, D. A., Darley-Usmar, V. M., Symons, M. C., and Wilson, M. T. (1996) Free Radic. Res. 25, 117–123[Medline] [Order article via Infotrieve]
  19. Herold, S., and Rehmann, F. J. (2003) Free Radic. Biol. Med. 34, 531–545[CrossRef][Medline] [Order article via Infotrieve]
  20. Radi, R. (1998) Chem. Res. Toxicol. 11, 720–721[CrossRef][Medline] [Order article via Infotrieve]
  21. Minetti, M., Pietraforte, D., Carbone, V., Salzano, A. M., Scorza, G., and Marino, G. (2000) Biochemistry 39, 6689–6697[CrossRef][Medline] [Order article via Infotrieve]
  22. Radi, R., Peluffo, G., Alvarez, M. N., Naviliat, M., and Cayota, A. (2001) Free Radic. Biol. Med. 30, 463–488[CrossRef